Prospective Study
Copyright ©The Author(s) 2022.
World J Transplant. Oct 18, 2022; 12(10): 313-324
Published online Oct 18, 2022. doi: 10.5500/wjt.v12.i10.313
Table 5 Changes in T lymphocyte subpopulations at T0, T3, and T6 time points in patients with panel reactive antibodies (+)
Parameter
T0
T3
T6
P value
Lymphocyte, %17.8 (11.2-40)16.4 (7.5-36.8)20.9 (12.2-36.4)0.07
Lymphocyte, cells/μL1100 (700-2600)1300 (700-3600)1700 (525-3200)0.009
CD4+, %41.5 (25.3-59.5)42.3 (29.2-65.3)46.5 (27.4-62)NS
CD4+, cells/μL435 (253-1362.4)548.9 (292-1371.3)744 (220-1888)0.008
CD8+, %23.4 (10.5-53.1)27.4 (10.3-53.6)29.9 (11.6-56.2)0.005
CD8+, cells/μL294.9 (91.7-665.6)408 (123.6-1234.8)504.9 (114.4-955.4)< 0.0001
CD4CD28null, %7.2 (0-32.1)5.3 (0.2-24.8)4 (0.1-28.6)NS
CD4CD28null, cells/μL27.3 (0-206)22.8 (1.5-234)24.2 (1.3-244)NS
CD8CD28null, %48.4 (15.1-91.5)47.1 (10.7-82.1)36.5 (7.7-82)NS
CD8CD28null, cells/μL122.2 (13-583)200 (19-547)160 (22-726)NS
CD16/56, %18.4 (4.4-34.2)11.4 (2.9-26)7.9 (3-24.6)< 0.0001
CD16/56, cells/μL190.4 (94.8-393.6)157.5 (34.8-450)135.7 (23.76-385.7)0.07
Tregs, %, on CD44.2 (1.5-7.3)3.3 (1.2-6.8)4.4 (1.4-8.6)NS
Tregs, cells/μL18.9 (5.8-73.5)20.9 (7.4-65.8)26.7 (8.5-103.8)NS